These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23732954)

  • 21. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts".
    Wyman JF; Lavins ES; Engelhart D; Armstrong EJ; Snell KD; Boggs PD; Taylor SM; Norris RN; Miller FP
    J Anal Toxicol; 2013 Apr; 37(3):182-5. PubMed ID: 23408250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats.
    Oliver CF; Simmons SJ; Nayak SU; Smith GR; Reitz AB; Rawls SM
    Drug Alcohol Depend; 2018 May; 186():75-79. PubMed ID: 29550625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic cathinone exposures reported to Texas poison centers.
    Forrester MB
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):609-15. PubMed ID: 22541001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergency department visits after use of a drug sold as "bath salts"--Michigan, November 13, 2010-March 31, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(19):624-7. PubMed ID: 21597456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of "bath salts" use patterns within an online sample of users in the United States.
    Johnson PS; Johnson MW
    J Psychoactive Drugs; 2014; 46(5):369-78. PubMed ID: 25364987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta-cathinone derivatives--a new generation of dangerous psychostimulant "designer drugs"].
    Zawilska JB; Słomiak K; Wasiak M; Woźniak P; Massalski M; Krupa E; Wojcieszak JŁ
    Przegl Lek; 2013; 70(6):386-91. PubMed ID: 24052975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designer cathinones--an emerging class of novel recreational drugs.
    Zawilska JB; Wojcieszak J
    Forensic Sci Int; 2013 Sep; 231(1-3):42-53. PubMed ID: 23890615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.
    Seely KA; Patton AL; Moran CL; Womack ML; Prather PL; Fantegrossi WE; Radominska-Pandya A; Endres GW; Channell KB; Smith NH; McCain KR; James LP; Moran JH
    Forensic Sci Int; 2013 Dec; 233(1-3):416-22. PubMed ID: 24314548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results.
    Marinetti LJ; Antonides HM
    J Anal Toxicol; 2013 Apr; 37(3):135-46. PubMed ID: 23361867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).
    Dargan PI; Sedefov R; Gallegos A; Wood DM
    Drug Test Anal; 2011; 3(7-8):454-63. PubMed ID: 21755604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Not-so-clean fun: a profile of bath salt users among a college sample in the United States.
    Miller BL; Stogner JM
    J Psychoactive Drugs; 2014; 46(2):147-53. PubMed ID: 25052791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of "bath salts" purchased from California stores and the internet.
    Schneir A; Ly BT; Casagrande K; Darracq M; Offerman SR; Thornton S; Smollin C; Vohra R; Rangun C; Tomaszewski C; Gerona RR
    Clin Toxicol (Phila); 2014 Aug; 52(7):651-8. PubMed ID: 25089721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are "bath salts" the next generation of stimulant abuse?
    Winder GS; Stern N; Hosanagar A
    J Subst Abuse Treat; 2013 Jan; 44(1):42-5. PubMed ID: 22445773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical toxicology of newer recreational drugs.
    Hill SL; Thomas SH
    Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mephedrone, the new designer drug of abuse: pharmacokinetics, pharmacodynamics and clinical and forensic issues].
    Ribeiro E; Magalhães T; Dinis-Oliveira RJ
    Acta Med Port; 2012; 25(2):111-7. PubMed ID: 22985922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bath salts intoxication: a case series.
    Imam SF; Patel H; Mahmoud M; Prakash NA; King MS; Fremont RD
    J Emerg Med; 2013 Sep; 45(3):361-5. PubMed ID: 23827164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?
    Meyers K; Kaynak Ö; Bresani E; Curtis B; McNamara A; Brownfield K; Kirby KC
    Int J Drug Policy; 2015 Jul; 26(7):670-4. PubMed ID: 25641258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.